Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 587

1.

Presidential Round Table: A Report from the GRAPPA Annual Meeting.

Gladman DD, Mease PJ, Boehncke WH, Helliwell PS, Callis Duffin K.

J Rheumatol. 2016 May;43(5):986-9. doi: 10.3899/jrheum.160120.

PMID:
27134275
2.

GRAPPA 2015 Research and Education Project Reports.

Mease PJ, Helliwell PS, Boehncke WH, Coates LC, FitzGerald O, Gladman DD, Deodhar AA, Callis Duffin K.

J Rheumatol. 2016 May;43(5):979-85. doi: 10.3899/jrheum.160119.

PMID:
27134274
3.

Let's Talk about Inclusion: A Report on Patient Research Partner Involvement in the GRAPPA 2015 Annual Meeting.

de Wit M, Campbell W, Coates LC, Gladman DD, James J, Lindsay CA, MacDonald R, Moverley AR, Ogdie A, Orbai AM, O'Sullivan D, Parkinson A, Steinkoenig I, Tillett W, Goel N.

J Rheumatol. 2016 May;43(5):970-3. doi: 10.3899/jrheum.160117.

PMID:
27134272
4.

Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.

Orbai AM, Mease PJ, de Wit M, Kalyoncu U, Campbell W, Tillett W, Eder L, Elmamoun M, FitzGerald O, Gladman DD, Goel N, Gossec L, Lindsay CA, Steinkoenig I, Helliwell PS, McHugh NJ, Strand V, Ogdie A.

J Rheumatol. 2016 May;43(5):965-9. doi: 10.3899/jrheum.160116.

5.

Prologue: 2015 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

Boehncke WH, Gladman DD, Helliwell PS.

J Rheumatol. 2016 May;43(5):949-51. doi: 10.3899/jrheum.160112.

PMID:
27134267
6.

Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort.

Urowitz MB, Gladman DD, Anderson NM, Su J, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke A, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg D, Rahman A, Merrill J, Ginzler E, Alarcón GS, Fessler BF, Petri M, Bruce IN, Khamashta M, Aranow C, Dooley M, Manzi S, Ramsey-Goldman R, Sturfelt G, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian KC, Ỉnanç M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T.

Lupus Sci Med. 2016 Apr 12;3(1):e000143. doi: 10.1136/lupus-2015-000143. eCollection 2016.

7.

Clinical and Demographic Characteristics of Erosion-free and Erosion-present Status in Psoriatic Arthritis in a Cohort Study.

Touma Z, Thavaneswaran A, Chandran V, Pellett F, Cook RJ, Gladman DD.

J Rheumatol. 2016 Apr 1. pii: jrheum.150466. [Epub ahead of print]

PMID:
27036389
8.

A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach.

Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Fessler BJ, Manzi S, Nived O, Sturfelt GK, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Sam Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Farewell V.

Arthritis Rheumatol. 2016 Mar 18. doi: 10.1002/art.39674. [Epub ahead of print]

PMID:
26991067
9.

Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set.

Kalyoncu U, Ogdie A, Campbell W, Bingham CO 3rd, de Wit M, Gladman DD, Mease P, Steinkoenig I, Strand V, Riese VG, Orbai AM.

RMD Open. 2016 Mar 3;2(1):e000217. doi: 10.1136/rmdopen-2015-000217. eCollection 2016.

10.

Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus.

Urowitz MB, Ibañez D, Su J, Gladman DD.

J Rheumatol. 2016 May;43(5):875-9. doi: 10.3899/jrheum.150983. Epub 2016 Feb 15.

PMID:
26879352
11.

Does renin-angiotensin system blockade protect lupus nephritis patients from atherosclerotic cardiovascular events? A case-control study.

Tselios K, Gladman DD, Su J, Urowitz MB.

Arthritis Care Res (Hoboken). 2016 Feb 11. doi: 10.1002/acr.22857. [Epub ahead of print]

PMID:
26866934
12.

Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.

Tselios K, Gladman DD, Su J, Urowitz MB.

J Rheumatol. 2016 Mar;43(3):552-8. doi: 10.3899/jrheum.150779. Epub 2016 Jan 15.

PMID:
26773121
13.

Development of System-level Performance Measures for Evaluation of Models of Care for Inflammatory Arthritis in Canada.

Barber CE, Marshall DA, Mosher DP, Akhavan P, Tucker L, Houghton K, Batthish M, Levy DM, Schmeling H, Ellsworth J, Tibollo H, Grant S, Khodyakov D, Lacaille D; Arthritis Alliance of Canada Performance Measurement Development Panel.

J Rheumatol. 2016 Mar;43(3):530-40. doi: 10.3899/jrheum.150839. Epub 2016 Jan 15.

14.

The Incidence and Predictors of Infection in Psoriasis and Psoriatic Arthritis: Results from Longitudinal Observational Cohorts.

Haddad A, Li S, Thavaneswaran A, Cook RJ, Chandran V, Gladman DD.

J Rheumatol. 2016 Feb;43(2):362-6. doi: 10.3899/jrheum.140067. Epub 2016 Jan 15.

PMID:
26773102
15.

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.

Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW, Bautista-Molano W, Boehncke WH, Campbell W, Cauli A, Espinoza LR, FitzGerald O, Gladman DD, Gottlieb A, Helliwell PS, Husni ME, Love TJ, Lubrano E, McHugh N, Nash P, Ogdie A, Orbai AM, Parkinson A, O'Sullivan D, Rosen CF, Schwartzman S, Siegel EL, Toloza S, Tuong W, Ritchlin CT.

Arthritis Rheumatol. 2016 May;68(5):1060-71. doi: 10.1002/art.39573. Epub 2016 Mar 23.

PMID:
26749174
16.

Dyslipidemia in systemic lupus erythematosus: just another comorbidity?

Tselios K, Koumaras C, Gladman DD, Urowitz MB.

Semin Arthritis Rheum. 2016 Apr;45(5):604-10. doi: 10.1016/j.semarthrit.2015.10.010. Epub 2015 Oct 29.

PMID:
26711309
17.

Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture.

Stuart PE, Nair RP, Tsoi LC, Tejasvi T, Das S, Kang HM, Ellinghaus E, Chandran V, Callis-Duffin K, Ike R, Li Y, Wen X, Enerbäck C, Gudjonsson JE, Kõks S, Kingo K, Esko T, Mrowietz U, Reis A, Wichmann HE, Gieger C, Hoffmann P, Nöthen MM, Winkelmann J, Kunz M, Moreta EG, Mease PJ, Ritchlin CT, Bowcock AM, Krueger GG, Lim HW, Weidinger S, Weichenthal M, Voorhees JJ, Rahman P, Gregersen PK, Franke A, Gladman DD, Abecasis GR, Elder JT.

Am J Hum Genet. 2015 Dec 3;97(6):816-36. doi: 10.1016/j.ajhg.2015.10.019. Epub 2015 Nov 28.

PMID:
26626624
18.

Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus.

Tselios K, Gladman DD, Su J, Urowitz MB.

Lupus. 2016 Apr;25(5):532-5. doi: 10.1177/0961203315617845. Epub 2015 Nov 18.

PMID:
26585070
19.

Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review.

Tselios K, Sheane BJ, Gladman DD, Urowitz MB.

J Rheumatol. 2016 Jan;43(1):54-65. doi: 10.3899/jrheum.150460. Epub 2015 Nov 15.

PMID:
26568591
20.

Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.

Steiman AJ, Gladman DD, Ibañez D, Noamani B, Landolt-Marticorena C, Urowitz MB, Wither JE.

J Rheumatol. 2015 Dec;42(12):2318-26. doi: 10.3899/jrheum.150040. Epub 2015 Nov 15.

PMID:
26568589
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk